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Abstract
In addition to motor symptoms, patients with movement disorders often complain of psychiatric
disturbances, including mood, anxiety, and impulse-control disorders and psychosis. These abnormalities
are often misdiagnosed and left untreated, thus resulting in a worse prognosis and lower quality of life.
Besides the use of standard pharmacological treatments, psychiatric abnormalities can be treated by means
of nonpharmacological approaches. These approaches include various types of psychological therapies, the
most widely used being cognitive behavioral therapy (CBT). We reviewed all articles, conducted until 2014,
that contained primary data derived from clinical trials and case reports on the effect of CBT in the most
common movement disorders. One randomized, controlled study and several uncontrolled studies on the
efÖcacy of CBT in Parkinson's disease (PD) have shown a short-term beneÖt of depression and anxiety. In
Tourette's syndrome (TS), CBT has been assessed in a number of large controlled clinical trials that have
demonstrated an improvement in psychiatric disturbances and tics. There are no controlled studies on the
efÖcacy of CBT in other types of movement disorders, such as dystonia, Huntington's disease, and essential
tremor. Only a limited number of studies have evaluated the efÖcacy of CBT in the management of
psychiatric disorders in movement disorders. The evidence available suggests that CBT is useful in TS and
probably useful in PD. We recommend the planning of randomized, controlled clinical trials to investigate
the effects of CBT and group CBT in the treatment of psychiatric disturbances in movement disorders.
Patients with movement disorders often complain of nonmotor symptoms, including psychiatric
disturbances. Parkinson's disease (PD) is characterized by a high prevalence of depression, anxiety, impulse-
control disorders (ICDs), and psychosis.[1, 2] Patients with Tourette's syndrome (TS) present a high
frequency of attention deÖcit hyperactivity disorder, obsessive-compulsive disorders (OCD), abnormal
social behavior, self-injury behavior, anxiety, depression, addictive disorders, and anger control problems.
[3-5] Depressive and anxiety symptoms and social phobia are present in patients with focal dystonia
(blepharospasm, cervical dystonia, laryngeal dystonia, and arm dystonia) or generalized dystonia.[6, 7] OCD
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is a consistent comorbid disorder in myoclonic dystonia.[8] In Huntington's disease (HD), psychiatric
symptoms, particularly depression and psychosis, are a cardinal manifestation that may develop several
years before motor or cognitive deÖcits and are extremely burdening for patients, families, and caregivers.
[9] Finally, essential tremor (ET) patients have an increased frequency of mood disorders, anxiety disorders,
social phobia, and personality disturbances.[10, 11] In general, the aforementioned psychiatric disorders
are often misdiagnosed and frequently left untreated, which leads to a worse prognosis and lower quality of
life.
Pharmacological treatments are generally used for treatment of psychiatric disturbances in the various
movement disorders,[12] though the efÖcacy of such treatments is often unsatisfactory and may be
associated with a deterioration in motor functions.[13] Nonpharmacological management may therefore be
a useful alternative in treatment of psychiatric abnormalities in movement disorders. The best-known
psychological therapies and social interventions currently available include psychodynamic therapy, family
therapy, and cognitive behavioural therapy (CBT). CBT is a psychotherapeutic approach that addresses
dysfunctional beliefs and emotions, maladaptive behaviors, and cognitive processes and contents through a
number of goal-oriented, explicit systematic procedures. CBT highlights the centrality of a person's
thoughts, appraisals, and beliefs in guiding feelings and actions, and focuses on the identiÖcation and
modiÖcation of dysfunctional thoughts to improve affect regulation. CBT is also based on the assumption
that emotional reaction and behavior depend on cognitive processing in a speciÖc situation. CBT aims to
introduce changes in the inner experience of the patient by means of cognitive and emotional restructuring
through thoughts, beliefs, memories, feelings, and emotions. Changes in inner experience develop in a
temporal continuum with a review of the past and planning for the future. By understanding interpersonal
patterns and pathological beliefs, patients change their inner experiences through critical re×ection and by
experiencing alternative behavior. Various techniques, each of which is speciÖc to the different disorders,
are currently available, including cognitive, behavioral, environmental, biological, supportive, interpersonal,
and experiential treatment.[14]
CBT is used for treatment of a variety of primary psychiatric conditions, including mood, psychosis, anxiety,
personality, and eating disorders,[15-18] and has successfully been used in various medical conditions with
a psychological component, including chronic or acute pain, chronic fatigue syndrome, premenstrual
syndrome, colitis, sleep disorders, obesity, and neurological diseases.[19, 20] Several factors make CBT
particularly suited to treatment of psychiatric symptoms associated with movement disorders. Movement
disorders are often associated with mood disorder, OCD, and fatigue, which are pathological conditions in
which CBT is known to be effective. The aim of this article was to review studies that have employed CBT
for treatment of psychiatric disturbances in the most common movement disorders (i.e., PD, TS, dystonia,
HD, and ET) and evaluate their efÖcacy in these conditions.
Materials and Methods
A search of two electronic databases was performed to identify relevant articles: PubMed/Medline and
PsycInfo. Our initial search strategy included the main term, that is, “Cognitive Behavioral Therapy”,
combined with the following: “movement disorders”, “Parkinson's Disease”, “Dystonia”, “Tourette
Syndrome”, “Huntington's disease”, “Tic Disorders”, and “Essential Tremor”. Research was limited to studies
on humans that were written in English and addressed both movement disorders and CBT. We included all
articles that contained primary data derived from clinical trials or longitudinal or cross-sectional studies
conducted until 2014. We evaluated articles that had a Diagnostic and Statistical Manual (DSM) or
International ClassiÖcation of Diseases diagnosis of AXIS-I disorder, that used interventions with
psychiatric disturbances as the primary focus, that adopted a controlled design, and that employed
standardized primary outcome measures. Because no controlled studies were found for dystonia, HD, and
ET, open studies and case series were also evaluated for these disorders. The level of evidence was based on
neurological management guidelines drawn up by the European Federation of Neurological Societies.[21]
CBT in PD
Table 1 provides an overview of the participants' characteristics, experimental designs, and main Öndings of
studies that investigated the efÖcacy of CBT in the treatment of psychiatric disorders in PD. A randomized,
controlled clinical trial (RCT) compared the efÖcacy of individually administered CBT with that of clinical
monitoring alone (i.e., with no new treatment) for depression in 80 PD patients, as measured by changes in
the Hamilton Depression Rating Scale (HAM-D) score.[22] CBT-treated patients received 10 weekly
individualized sessions (60–75 minutes), whereas the control arm participants maintained stable medical
regimens with no new interventions. The results revealed a signiÖcant improvement in both standardized
depression and anxiety measures in the CBT group (the mean HAM-D score at the end of the study was
13.6 in the CBT group and 19.3 in the clinical-monitoring-alone group, whereas the mean Beck Depression
Inventory [BDI] score was 9.7 in the CBT group and 17.4 in the clinical-monitoring-alone group). Secondary
outcomes were anxiety, negative thoughts, sleep, quality of life, coping, social support, caregiver burden,
and PD symptoms. Quality of life and social support were measured by the social functioning, physical role
limitations, and physical disability subscales of the Medical Outcomes Study Short-Form Health Survey and
by the Social Feedback Questionnaire. No signiÖcant group-by-time improvements were noted for
secondary outcomes, including social support; however, signiÖcant changes from baseline were observed at
the Medical Outcomes Study Short-Form Health Survey. SpeciÖc modiÖcations from standard CBT include
a greater emphasis on behavioral and anxiety management, as well as inclusion of a supplemental caregiver
educational program. Individual sessions incorporated exercise, behavioral activation, thought monitoring
and restructuring, relaxation training, worry control, and sleep hygiene. The CBT group displayed greater
improvements in quality of life, coping, and anxiety, as well as a lower degree of motor decline. The
improvement persisted at the 1-month follow-up. In an open treatment study[23] on 8 depressed PD
patients, 12 weekly individual CBT sessions (50 minutes) improved depression, as measured by HAM-D
scores, after the intervention, with 4 patients meeting remission criteria for depression (deÖned as HAM-
D ≤7). The CBT session was highly structured and included setting agenda, mood check, bridge from last
session, today's agenda items, homework assignment, summary of session, and feedback from patient. CBT
performed in 15 PD patients[24] led to a signiÖcant improvement in depression measures and negative
cognitions, and an increased perception of social support over the course of treatment, as well as to a mild,
though not signiÖcant, improvement in anxiety; mood improvement was sustained at the 1-month follow-
up. Patients' caregivers attended three to four psychoeducational sessions, which were held separately
from patients' treatment sessions and focused on strategies for offering appropriate support and ways to
respond to patients' negative thoughts in a targeted manner. The CBT sessions involved training in stress
management, behavioral changes, sleep hygiene, relaxation techniques, and cognitive restructuring. Other
studies have assessed the efÖcacy of CBT therapy in depression in small samples of PD patients.[25-27]
Two studies have evaluated the efÖcacy of group CBT for psychiatric symptoms in PD.[28, 29] Group CBT
proved useful in a waitlist-controlled trial conducted on 18 PD patients.[28] PD patients were included if
they were diagnosed with at least one depressive and/or anxiety disorder according to DSM-IV criteria.
Secondary outcomes were quality of life and depressive and anxious cognitions. The CBT techniques
include psychoeducation, relaxation training, cognitive therapy, problem solving, and behavioral activation.
A number of PD-speciÖc adaptations were implemented. Group CBT patients displayed a signiÖcant
improvement in depressive symptoms (mean reduction in depression of 3.91 compared with an increase of
0.29 for waitlist participants; P = 0.011), though not in anxiety symptoms (mean reduction in anxiety of 3.64
compared with 0.43 for waitlist participants; P = 0.25). Group treatment for individuals with PD affords
several therapeutic advantages; as functional impairment worsens, individuals with chronic neurological
diseases tend to experience increased stigma, withdrawal, and social isolation, which play a signiÖcant role
in both the development and persistence of psychiatric comorbidity. The researchers of one open-label
study showed that group CBT was useful in the treatment of depression and anxiety.[29] The improvement
in psychiatric symptoms was accompanied by a reduction in motor symptoms and an improvement in
quality of life, assessed with the Parkinson's Disease Quality of Life Questionnaire. The group CBT
administered to the patients consisted of standard group CBT that was focused on the link between
psychological distress and physical illness. Some sessions were aimed at understanding patients'
vulnerability and their fear of the future; speciÖc PD sessions were also held and included describing and
sharing emotions after the diagnosis of PD, observation of mood changes, acceptance and evaluation of
disease severity, and personal beliefs regarding the neurological disease, analysis of the content of thought
and emotions related to the underlying disease, and the consequences of behavior (using the classic scheme
of self-observation).
Swipe table to view complete data
Table 1. Studies designed to investigate the efÖcacy of CBT on psychiatric disturbances in PD patients
Reference Primary Aim Patients (n) Intervention Main Outcome
Measures
Main Findings
Dobkin et al.
[22]
EfÖcacy of CBT in
PD patients with
depression
41 CBT, 39
controls
10 weekly
individual sessions
of CBT vs. clinical
monitoring alone
HAM-D, HAM-A, BDI SigniÖcant improvement in
depression, anxiety, quality
of life, coping, and motor
decline in CBT group
Farabaugh
et al.[23]
EfÖcacy of CBT on
depression in PD
8 12 weekly
individual sessions
of CBT
HAM-D SigniÖcant improvement in
depression; remission in
57% of participants
Dobkin et al.
[24]
EfÖcacy of CBT on
depression in PD
15 14 weekly sessions
of CBT; 3–4
additional
psychoeducational
sessions for
caregivers
HAM-D, BDI, STAI Improvement in depressive
symptoms and negative
cognitions; increased
perception of social
support
Dobkin et al.
[25]
EfÖcacy of CBT on
depression in PD
3 12–14 sessions of
cognitive-
behavioral
intervention; 3–4
separate caregiver
psychoeducational
sessions
HAM-D, STAI, BDI, IQ,
AIFQ
SigniÖcant improvement in
depressive symptoms
Feeney et al.
[26]
EfÖcacy of CBT on
anxiety and
depression in PD
4 8 weekly group
sessions of CBT
BDI-II, STAI-S SigniÖcant improvement in
depression; no signiÖcant
improvement in anxiety
Cole and
Vaughan[27]
EfÖcacy of home-
based CBT on
depression in PD
5 7 weekly brief
home-based
sessions of CBT
GDS-15, BDI-II, PDQL Four individuals
demonstrated a clinically
reliable reduction in
symptoms according to the
GDS scores.
Reference Primary Aim Patients (n) Intervention Main Outcome
Measures
Main Findings
1. ICBSS, Impulse Control Behavior Symptom Scale; NPI, Neuropsychiatric Inventory; PDSS, Parkinson's disease sleep
scale; HAM-A, Hamilton Anxiety Rating Scale; PHQ-9, Patient Health Questionnaire; STAI, State-Trait Anxiety
Inventory; IQ, Inference Questionnaire; AIFQ, Adaptive Inferential Feedback Questionnaire; STAI-S, Subscale of the
State and Trait Anxiety Inventory; BDI-II, Beck Depression Inventory–Second Edition; GDS-15, Geriatric Depression
Scale; PDQL, Parkinson's Disease Quality of Life Questionnaire; PSQI, Pittsburgh Sleep Quality Index-sleep
disturbances subscale; FSS, the fatigue severity scale; MoCA, Montreal Cognitive Assessment; DASS-21, Depression,
Anxiety, Stress Scale-21; BPRS, Brief Psychiatric Rating Scale.
Troeung
et al.[28]
EfÖcacy of a group
CBT for
depression and
anxiety in PD
patients
18 8-week group CBT
treatment or
waitlist (8-week
clinical monitoring
preceding
treatment)
DASS-21 at Time 1
(pretreatment), Time 2
(post-
treatment/postwaitlist)
and 1- and 6-month
follow-ups
Participants who received
CBT reported greater
reductions in depression
and anxiety than waitlist
participants. Improvement
was maintained at follow-
up period.
Berardelli
et al.[29]
EfÖcacy of a group
CBT for
depression and
anxiety in PD
patients
7 12-week group
CBT treatment
CGI, HAM-D, HAM-A,
BPRS
SigniÖcant improvement in
depressive and anxiety
symptoms
Dobkin et al.
[30]
Telephone-based
CBT on
depression in PD
patients
21 10 weekly sessions
with behavioral
activation; 4
separate caregivers
administered
educational
sessions.
HAM-D 17, caregiver
burden, sleep
Improvement in depressive
symptoms
Veazey et al.
[31]
EfÖcacy of
telephone-based
CBT on
depression and
anxiety in PD
patients
5 8 weekly
telephone-based
sessions of CBT vs.
8 weekly telephone
calls of support
therapy
PHQ-9, BAI, PDQ-39 Improvement in depressive
and anxiety symptoms
Okai et al.
[32]
EfÖcacy of CBT in
PD patients with
impulse control
behaviors
28 12 weekly
individual sessions
of CBT vs. standard
medical care
CGI, NPI, ICBSS, BAI,
BDI
SigniÖcant improvement in
ICD severity, depression,
and anxiety in CBT group
Yang and
Petrini[33]
EfÖcacy of CBT on
sleep disorders in
PD patients
22 4 weekly sessions
of CBT
PDSS, sleep diary SigniÖcant improvement in
total wake time, sleep
efÖciency, and PDSS score
in CBT group
Rios
Romenets
et al.[34]
EfÖcacy of CBT
with bright-light
therapy or
doxepin (10 mg
daily) for
insomnia in PD
patients
18 patients
were
randomized,
6 to each
group.
12-week sessions
of CBT
ISI, PSQI, PDQ-39, FSS,
MoCA, CGI
Compared to placebo,
doxepin and CBT improved
ISI, PSQI, and FSS. In CBT,
group was observed with a
decline in PDQ-39.
 
The effect of telephone-based CBT for depression in PD was investigated in 21 PD patients who met the
DSM-IV criteria for primary major depressive disorder, dysthymia, or a not otherwise speciÖed depressive
disorder.[30] All participants received 10 sessions of individually administered telephone-based CBT along
with four separate caregiver-administered educational sessions. Telephone sessions incorporated
behavioral activation, recommendations to gradually increase exercise, relaxation training, worry control,
sleep hygiene, and anxiety management techniques. Telephone-based CBT was associated with signiÖcant
improvements in the HAM-D 17; secondary endpoints included severity of depression and treatment
response, anxiety, negative thoughts, quality of life, social functioning, physical role limitations, coping,
social support, sleep, and caregiver burden. No signiÖcant effects were found on measures of quality of life
assessed with the quality-of-life subscales (social functioning, physical role limitations, and physical
disability) of the Medical Outcomes Short Form. The results were comparable to the additional in-person
CBT pilot studies for PD, thereby demonstrating that the beneÖcial effects of telephone psychotherapy
observed in other chronic medical conditions are not attenuated in PD. In another telephone-administered
CBT study on the treatment of depression in PD, patients were randomized to either a “CBT arm” or a
“support arm.”[31] SpeciÖc interventions included depression and anxiety education, relaxation training,
cognitive therapy, problem solving, activity scheduling, exposure, and sleep-management skills. CBT arm
patients displayed a mild improvement in depression and a signiÖcant improvement in anxiety both post-
treatment and at the 1-month mark, whereas the support arm patients did not. Quality-of life dimensions
related to PD was assessed using the 39-item PD questionnaire (PDQ-39). The effect size was small for the
post-treatment time point, with no differences between CBT- and support-treated patients.
CBT has also been used in PD for treatment of other psychiatric disorders. An RCT based on 12 weekly CBT
sessions compared the efÖcacy of a CBT-based intervention with that of a control condition, both combined
with standard medical care, for the management of ICD in 45 PD patients.[32] The researchers used
standard treatments of ICD in the general population adapted for PD, with additional components on
communication and interpersonal relationships, executive dysfunction, and elements of case management.
CBT plus standard medical care was found to be more effective than standard medical care alone in
reducing severity of ICD in PD patients, as measured by the Clinical Global Impression (CGI) Assessment; in
addition, the CBT-based intervention improved depression and anxiety. A study on 22 PD patients with
insomnia[33] demonstrated that CBT facilitates improvement of sleep disorders. CBT sessions include
sleeping diary, reviewing participants' problems and expectations, and cognitive reconstruction; the main
aim was to improve sleep by reducing unnecessary worrying. In another controlled study,[34] CBT was
compared with doxepin and placebo for treatment of insomnia in PD patients. CBT treatment reduced the
Insomnia Severity Index (ISI; −7.8 ± 3.8 vs. −2.0 ± 3.9; P = 0.03) as well as the examiner-reported clinical
global impression of change (P = 0.006).
CBT in Chronic Tic Disorder and TS
Table 2 provides an overview of participants' characteristics, experimental design, and main Öndings.
Behavioral treatments used in chronic tic disorders (CTDs) and TS include standard CBT, habit reversal (HR)
training (HRT), and exposure with response prevention. A recent meta-analysis of behavior therapy for TS
identiÖed eight RCT studies, which included a total of 438 participants, and found a medium-to-large effect
size of behavioral treatments.[35] An RCT[36] on 232 patients with TS or CTD showed that a decrease of
25% of the Yale Global Tic Severity Scale (YGTSS) score was highly predictive of a positive response to
behavioral treatment. One trial on 6 TS patients showed that CBT, self-monitoring, and relaxation
techniques had a similar efÖcacy on tic severity.[37] The study by O'Connor et al.,[38] performed on 76
patients with either TS or CTD, assessed whether CBT is equally effective when combined with existing
medication or administered without medication. Measures included the Tourette Syndrome Global Scale
(TSGS), the Beck Anxiety Inventory (BAI), and the BDI. The results showed that CBT is effective both alone
and when combined with medications. TSGS total scores decreased signiÖcantly in both TS and CTD
patients, with an improvement of 49% being observed in the overall TSGS scores of medicated patients and
of 54% in nonmedicated patients. There was also a signiÖcant improvement in the BAI scores in the
nonmedicated group, though not in the medicated group, as well as a signiÖcant improvement in BDI scores
in both groups. A large, randomized trial focused on the effectiveness of comprehensive behavior therapy
(CBIT), compared with supportive psychotherapy, in 122 patients with TS or CTD.[40] After three monthly
booster sessions, patients who completed the treatment with behavior therapy displayed a signiÖcantly
greater decrease in the YGTSS from baseline to endpoint than the control treatment group (24.0 ± 6.47 to
17.8 ± 7.32 vs. 21.8 ± 6.59 to 19.3 ± 7.40; P < 0.001; effect size = 0.57). Twenty-four of the sixty-three
subjects (38.1%) in the CBIT group were rated as Much Improved or Very Much Improved on the CGI-
Improvement Scale, compared with only 4 of 63 subjects (6.8%) in the supportive therapy group
(P < 0.0001). Studies on the effectiveness of behavior therapies based on HRT in TS have yielded promising
results.[41, 42] HRT is a “multicomponent behavioral treatment package originally developed to address a
wide variety of repetitive behavior disorders.” These results conÖrmed the hypothesis that tics may be
suppressed for prolonged periods of time by means of response prevention.[42] The recently published
European clinical guidelines on nonpharmacological intervention for TS[43] suggest that HRT is an effective
treatment option for reducing tic severity. HRT consisted of awareness training, self-monitoring, relaxation
training, competing response training, and contingency management. A randomized trial to compare the
effects of HRT on tics, life satisfaction, and psychosocial functioning with those of supportive
psychotherapy was performed in outpatients with TS.[44] The researchers conÖrmed that HR did reduce,
whereas supportive psychotherapy did not reduce, tic severity over the course of treatment. Both groups
displayed an improvement in life satisfaction and psychosocial functioning measures during active
treatment. Reductions in tic severity (after HRT) and improvements in life satisfaction and psychosocial
functioning (after both HR and supportive psychotherapy) remained stable at the 6-month follow-up. The
effects of exposure plus response (ER) prevention were compared with those of HRT in 43 TS patients.[45]
As outcome measures, the researchers used the YGTSS, 15-minute tic frequency recordings monitored in
the hospital and 15-minute tic frequency recordings performed at home. Both treatment conditions
resulted in statistically signiÖcant improvements in all outcome measures (P < 0.001). No signiÖcant
differences emerged between the two treatment conditions in any of the outcome measures, although
there was a tendency in favor of ER on the YGTSS (P = 0.05). The same researchers did not report any
evidence of a rebound effect after ER prevention therapy sessions.[46]
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Table 2. Studies designed to investigate the efÖcacy of CBT on psychiatric disturbances in adult TS patients
Reference Primary Aim Patients
(n)
Intervention Main
Outcome
Measures
Main Findings
Jeon et al.
[36]
To compare 3
statistical
strategies for
classifying
positive treatment
response
232 TS
or CTD
patients
Comparison of behavioral
treatment to supportive
therapy.
YGTSS and
CGI-I
A 25% decrease on the YGTSS
predicted positive response on
the CGI-I
Peterson
and
Azrin[37]
EfÖcacy of HRT,
self-monitoring,
and relaxation
training
6 TS
patients
Counterbalanced design,
videotapes ratings
Tic severity Improvement in tic severity with
the 3 treatments
Reference Primary Aim Patients
(n)
Intervention Main
Outcome
Measures
Main Findings
1. SP, supportive psychotherapy.
O' Connor
et al.[38]
Evaluating the
effectiveness of
CBT with and
without
medication
76 TS or
CTD
patients
CBT in medicated or
unmedicated TS and CTD
patients
TSGS, BAI,
BDI
No differences in CBT efÖcacy
between medicated and
unmedicated patients
Wilhelm
et al.[39]
EfÖcacy of CBIT 122 TS
patients
8 sessions of CBIT vs. SP YGTSS, CGI-
I
CBIT was superior to control
treatment in reducing YGTSS
Total Tic score.
O' Connor
et al.[40]
EfÖcacy habit
reversal for the
management of
CTD and habit
disorder (HD)
47 CTD
and 43
habit
disorders
patients
4-month treatment
program vs. waitlist control
group; awareness training,
relaxation, and habit-
reversal training
YGTSS Changes in severity of TS
disorder in the habit reversal
therapy group
Deckersbach
et al.[41]
EfÖcacy of HRT vs.
SP
30 TS
patients
14 individual sessions of
HR or SP
YGTSS HR, but not SP, reduced tic
severity. Both groups improved
in life-satisfaction and
psychosocial functioning and
remained stable at the 6-month
follow-up.
Verdellen
et al.[43]
EfÖcacy of HRT 32 TS
patients
14 session of HR l vs. SP YGTSS Changes in severity of TS
disorder in the habit reversal
therapy group
Wilhelm
et al.[44]
Evaluate the
effect of ER vs. HR
43 TS
patients
Individual session of ER or
individual session of HR
YGTSS, tic
frequency
registrations
Both treatment conditions
resulted in statistically
signiÖcant improvements on all
outcome measures.
 
CBT has been also used, with good results, in children and adolescents with CTD and TS. A randomized,
observer-blind, controlled trial of 126 children and adolescents with severe TS or CTD was conducted to
determine the efÖcacy of a comprehensive behavioral intervention compared with supportive therapy and
education aimed at reducing tic severity.[47] A greater improvement in symptom severity was observed in
the group treated with a behavioral intervention. The results obtained in this group of children were
assessed from baseline to endpoint by means of the YGTSS and compared to a control treatment group
(24.7–17.1 in the treated group vs. 24.6–21.0 in the control group; P < 0.001; effect size = 0.68). A recent
study[42] on 126 children with either CTD or TS investigated the acute effects of behavior therapy on
secondary psychiatric symptoms and psychosocial functioning. Responders to behavior therapy at the end
of the acute phase were reassessed at 3- and 6-month follow-up visits. At 6 months post-treatment, a
positive response to behavior therapy was associated with decreased anxiety, disruptive behavior, and
family strain, as well as improved social functioning. A retrospective study conducted on children and
adolescents affected by OCD showed that the combination of CBT and sertraline in patients with a
comorbid tic disorder was more effective than CBT alone, sertraline alone, or placebo.[48]
CBT in Dystonia, HD, and ET
Only two studies have investigated the effects of CBT on psychiatric disturbances in patients with dystonia,
though neither adopted an experimental design. A case report of 1 patient with cervical dystonia reported
an improvement, which persisted at the 6-month follow-up, after CBT. In that case, CBT focused on
catastrophic thoughts and abnormal illness beliefs.[49] In another case report, a patient was successfully
treated, after three baseline assessments, by means of progressive relaxation, positive practice, and visual
feedback. The improvement in behavioral and physiological symptoms (depression and anxiety) continued
to be signiÖcant at the 2-year follow-up.[50] No controlled studies have speciÖcally assessed the efÖcacy of
CBT in HD. Only two studies that describe single cases are available. Freinhar et al., who investigated 1
patient with HD using psychopharmacological and behavioral therapy, reported improvements in
depressive and anxiety symptoms.[51] Another case report investigated the effectiveness of CBT in a
patient who experienced depression and anxiety symptoms following a positive predictive test result for
HD. CBT, focused on negative automatic thoughts, effectively reduced the patient's affective, behavioral,
and physical symptoms, even at the 3- and 6-month follow-up examinations.[52] Last, although ET is
frequently associated with signiÖcant physical and psychosocial disability, as well as with an increased
frequency of mood and anxiety disorders, particularly social phobia and personality disturbances, no
studies have assessed whether CBT leads to an improvement in psychiatric disturbances in patients with
ET.
Discussion
Given that psychiatric disturbances are one of the main determinants of quality of life in patients with
movement disorders, alternative therapeutic interventions to pharmacological therapy may be useful in
such patients.[13, 53] In the present review, we examined clinical studies that assessed the effect of
individual CBT and group CBT in the treatment of psychiatric disorders in the most common movement
disorders. In PD, the majority of therapeutic interventions consisted of individual sessions of CBT. In two
studies, treatments were conducted telephonically. Most interventions consisted of CBT alone, with few
using a “mixed” approach combining CBT with other techniques. The efÖcacy of CBT in PD was tested using
various outcome measures and interventions. Studies reported a signiÖcant improvement in depressive and
anxiety symptoms when CBT was compared to placebo. Some of these studies also showed that the beneÖt
of CBT was maintained in the follow-up period, though none evaluated the patients for more than
3 months. Initial evidence also supported the use of group CBT in PD. In conclusion, the results of one
randomized, controlled study and several uncontrolled studies suggest that CBT applied to PD is probably
effective (level B). However, further studies, conducted on larger patient samples and with longer
observation periods, are warranted to conÖrm the efÖcacy and feasibility of CBT in PD. Another limitation
of previous CBT studies in PD is that it is still unclear whether CBT has any in×uence on motor symptoms.
More-deÖnite conclusions can be drawn on the efÖcacy of CBT in CTD and TS. Indeed, CBT and HRT have
been assessed in a number of large, controlled, clinical trials in TS patients, conducted on adults as well as
on children and adolescents, who generally displayed an improvement in psychiatric disturbances and tics.
Eight randomized, controlled studies on TS based on an appropriate sample size suggest that CBT,
particularly behavioral techniques such as HRT and exposure with response prevention, is effective,
yielding a level A of evidence (established efÖcacy). The efÖcacy of CBT in this condition is proven for both
psychiatric disorders and tics. No conclusions can be drawn on the effects of CBT in the treatment of
psychiatric disorders in dystonia and HD. The only published reports are based on case reports that point to
a possible beneÖt in a range of psychiatric symptoms. No studies have been published on the effects of CBT
in ET.
CBT leads to changes in brain areas that play important roles in emotional processing and emotion
regulation. In patients with major depression, CBT is associated with activation of the prefrontal cortex, an
increased metabolism in the hippocampus and dorsal cingulated cortex, and a decreased metabolism in the
dorsal, ventral, and medial frontal cortex.[54] In OCD patients, CBT led to a reduction in blood ×ow in the
caudate nucleus.[55] In phobia, brief courses of behavioral therapy led to marked reductions in paralimbic
responses to offensive stimuli, which were in keeping with the clinical improvement.[56] By activating
cortical processing through conscious control of thoughts and feelings, CBT enhances left cortical
processing, inhibiting and regulating right hemispheric balance and subcortical activation. From the studies
outlined above, it appears that CBT, when used in the treatment of primary psychiatric disorders, is
associated with changes in speciÖc brain networks that are, at least in part, associated with the
pathophysiology of the various movement disorders. It may thus be hypothesized that the clinical beneÖt of
a psychotherapeutic approach to the treatment of psychiatric symptoms in movement disorders may
induce changes in brain areas underlying the pathophysiology of motor disturbances in these conditions. It
is therefore possible that the clinical beneÖt of a psychotherapeutic approach to treatment of psychiatric
symptoms in movement disorders may induce changes in brain areas underlying the pathophysiology of
motor disturbances in these conditions.[57]
In conclusion, CBT may make a positive contribution to the treatment of psychiatric disturbances in
movement disorders. Further trials on PD are needed to shed more light on the effect of both individual and
group CBT. CBT trials should include PD patients in different stages of disease and should be designed to
assess both motor and nonmotor symptoms. An evaluation of the effects of CBT on caregiver burden would
also be useful. Controlled trials are needed to study the effect of individual and group CBT in patients with
dystonia; given that cervical dystonia patients are those most likely to be affected by depression, anxiety,
and coping problems, they are also those who may beneÖt most from psychotherapies. In ET, CBT,
particularly group CBT, should include patients whose age, severity of tremor, and functional impairment
are comparable. It is difÖcult to determine whether CBT may also be useful in HD patients, and inclusion in
trials on HD should be restricted to patients with no or mild cognitive impairment or to mutation carriers;
CBT may also be a useful aid to patients' caregivers.
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